Truvian raises $105 million to commercialize its automated blood-testing platform


Truvian, a startup developing an automated blood-testing platform, has raised $105 million to commercialize its product.Read More

Related Articles

Contemplating automated testing? Calculate your ROI first

In software development, speed has become the defining characteristic of product launches. It sets the standard we can’t really escape anymore. It places demands on market players both old and new: release now, fix the issues later. Launch the feature today or watch your competitors outpace you. Meet the deadline or lose a vitally important partner/client.  These are all thoughts and ideas most product managers, CTOs, and team leads have had (or heard). In part, I think the culprit for this state of affairs has been automation itself, as it has streamlined so many tech processes across industries and has… This story continues at The Next Web


Your email address will not be published. Required fields are marked *

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about chronicles from TreatMyBrand directly in your inbox